APA-referens (7:e uppl.)

Eikelboom, J., Bosch, J., Connolly, S., Tyrwitt, J., Fox, K., Muehlhofer, E., . . . Yusuf, S. (2022). Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease. European heart journal. Cardiovascular pharmacotherapy, 8(8), 786-795. https://doi.org/10.1093/ehjcvp/pvac023

Chicago-referens (17:e uppl.)

Eikelboom, JW, et al. "Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease." European Heart Journal. Cardiovascular Pharmacotherapy 8, no. 8 (2022): 786-795. https://doi.org/10.1093/ehjcvp/pvac023.

MLA-referens (9:e uppl.)

Eikelboom, JW, et al. "Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease." European Heart Journal. Cardiovascular Pharmacotherapy, vol. 8, no. 8, 2022, pp. 786-795, https://doi.org/10.1093/ehjcvp/pvac023.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.